Literature DB >> 22312609

Helicobacter pylori in First Nations and recent immigrant populations in Canada.

Nicola Jones1, Naoki Chiba, Carlo Fallone, Alan Thompson, Richard Hunt, Kevan Jacobson, Karen Goodman.   

Abstract

The diminishing prevalence of Helicobacter pylori infection among most segments of the Canadian population has led to changes in the etiologies and patterns of associated upper gastrointestinal diseases, including fewer peptic ulcers and their complications. Canadian Aboriginals and recent immigrants are among populations in which the prevalence of H pylori infection remains high and, therefore, the health risks imposed by H pylori remain a significant concern. Population-based strategies for H pylori eradication in groups with a low prevalence of infection are unlikely to be cost effective, but such measures are attractive in groups in which the prevalence rates of infection remain substantial. In addition to a lower prevalence of peptic ulcers and dyspepsia, the public health value of eradication may be particularly important if this leads to a reduction in the prevalence of gastric cancer in high prevalence groups. Therefore The Canadian Helicobacter Study Group held a conference that brought together experts in the field to address these issues, the results of which are reviewed in the present article. Canadians with the highest prevalence of H pylori infection are an appropriate focus for considering the health advantages of eradicating persistent infection. In Canadian communities with a high prevalence of both H pylori and gastric cancer, there remains an opportunity to test the hypothesis that H pylori infection is a treatable risk factor for malignancy.

Entities:  

Mesh:

Year:  2012        PMID: 22312609      PMCID: PMC3275412          DOI: 10.1155/2012/174529

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  68 in total

Review 1.  Clinical practice. Helicobacter pylori infection.

Authors:  Kenneth E L McColl
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer.

Authors:  Dong Wook Shin; Young Ho Yun; Il Ju Choi; Eurah Koh; Sang Min Park
Journal:  Helicobacter       Date:  2009-12       Impact factor: 5.753

3.  Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area.

Authors:  Chiaojung J Tsai; Sharon Perry; Luz Sanchez; Julie Parsonnet
Journal:  Am J Epidemiol       Date:  2005-07-13       Impact factor: 4.897

4.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

5.  Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

Authors:  Jyh-Ming Liou; Jaw-Town Lin; Chi-Yang Chang; Mei-Jyh Chen; Tsu-Yao Cheng; Yi-Chia Lee; Chien-Chuan Chen; Wang-Huei Sheng; Hsiu-Po Wang; Ming-Shiang Wu
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

6.  High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.

Authors:  Qinjuan Sun; Xiao Liang; Qing Zheng; Wenzhong Liu; Shudong Xiao; Weiqi Gu; Hong Lu
Journal:  Helicobacter       Date:  2010-06       Impact factor: 5.753

7.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

Review 8.  Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

9.  Helicobacter pylori infection among non-Native educators in Alaska.

Authors:  Tracey V Lynn; Michael G Bruce; Michael Landen; Michael Beller; Lisa Bulkow; Ben Gold; Alan Parkinson
Journal:  Int J Circumpolar Health       Date:  2007-04       Impact factor: 1.228

Review 10.  Helicobacter pylori and the prevention of gastric cancer.

Authors:  Terrence Sullivan; Fredrick D Ashbury; Carlo A Fallone; Farah Naja; Richard Schabas; Philip C Hébert; Richard Hunt; Nicola Jones
Journal:  Can J Gastroenterol       Date:  2004-05       Impact factor: 3.522

View more
  21 in total

1.  Helicobacter pylori and immigrant health.

Authors:  Nicola L Jones; Naoki Chiba; Carlo Fallone; Richard Hunt; Alan Thomson
Journal:  CMAJ       Date:  2012-01-10       Impact factor: 8.262

2.  What is the best regimen for Helicobacter pylori eradication in Canadian Arctic Aboriginals?

Authors:  Nicola Jones
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

3.  Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city.

Authors:  Wouter J den Hollander; I Lisanne Holster; Caroline M den Hoed; Frances van Deurzen; Anneke J van Vuuren; Vincent W Jaddoe; Albert Hofman; Guillermo I Perez Perez; Martin J Blaser; Henriëtte A Moll; Ernst J Kuipers
Journal:  J Gastroenterol Hepatol       Date:  2013-11       Impact factor: 4.029

4.  Prevalence of Helicobacter pylori in a First Nations population in northwestern Ontario.

Authors:  Abhimanyu Sethi; Monica Chaudhuri; Len Kelly; Wilma Hopman
Journal:  Can Fam Physician       Date:  2013-04       Impact factor: 3.275

5.  Helicobacter pylori status among patients undergoing gastroscopy in rural northern Alberta.

Authors:  Isabelle N Colmers-Gray; Ben Vandermeer; Robert I Greidanus; Michael R Kolber
Journal:  Can Fam Physician       Date:  2016-09       Impact factor: 3.275

6.  Prolonged treatment duration is required for successful Helicobacter pylori eradication with proton pump inhibitor triple therapy in Canada.

Authors:  Carlo A Fallone; Alan N Barkun; Andrew Szilagyi; Karl M Herba; Maida Sewitch; Myriam Martel; Stefanie S Fallone
Journal:  Can J Gastroenterol       Date:  2013-07       Impact factor: 3.522

7.  Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection.

Authors:  Hala El-Zimaity; Stefano Serra; Eva Szentgyorgyi; Rajkumar Vajpeyi; Amir Samani
Journal:  Can J Gastroenterol       Date:  2013-10       Impact factor: 3.522

8.  A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North.

Authors:  Amy L Morse; Karen J Goodman; Rachel Munday; Hsiu-Ju Chang; John Wi Morse; Monika Keelan; Janis Geary; Veldhuyzen van Zanten Sander
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

9.  Is the Utilization of Helicobacter pylori Stool Antigen Tests Appropriate in an Urban Canadian Population?

Authors:  Irene Ma; Maggie Guo; Dylan R Pillai; Deirdre L Church; Christopher Naugler
Journal:  Am J Clin Pathol       Date:  2020-04-15       Impact factor: 2.493

10.  Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients.

Authors:  Hideki Mori; Hidekazu Suzuki; Juntaro Matsuzaki; Tatsuhiro Masaoka; Takanori Kanai
Journal:  United European Gastroenterol J       Date:  2017-01-19       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.